Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: Implications for the molecular mechanism of action of the artemisinins

  • Paul M. O'Neill
  • , Sarah L. Rawe
  • , Kristina Borstnik
  • , Alison Miller
  • , Steve Ward
  • , Patrick G. Bray
  • , Jill Davies
  • , Chang Ho Oh
  • , Gary H. Posner

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Abstract

The aim of this study was to synthesise pure enantiomers of potent antimalarial I,2,4-trioxanes, which are related to the natural antimalarial ortemisinin, and then to assay each against a panel of Plasmodium falciparum strains. The working hypothesis was that if the artemisinin derivatives interact with a specific protein-target site, then there should be stereoselective differences in their activity. In five different P. falciparum isolates, however, the trioxane enantiomers (+)-7a, (-)-7a and (+)-7b, (-)-7b, showed the some level of in vitro antiparasitic activity.

Original languageEnglish
Pages (from-to)2048-2054
Number of pages7
JournalChemBioChem
Volume6
Issue number11
DOIs
Publication statusPublished - 1 Nov 2005

Keywords

  • Artemisinin
  • Asymmetric synthesis
  • Chirality
  • Drug design
  • Medicinal chemistry

Fingerprint

Dive into the research topics of 'Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: Implications for the molecular mechanism of action of the artemisinins'. Together they form a unique fingerprint.

Cite this